designer491 / iStock
Proponents of the shorter is better philosophy for antibiotic treatment of many common bacterial infections can add another study to their list: In results published this week in
JAMA, researchers reported that, in men who had presumed symptomatic urinary tract infections (UTIs) with no fever, 7 days of antibiotics was noninferior to 14 days for resolving symptoms.
The findings are from a randomized clinical trial conducted among men at two Veterans Affairs (VA) hospitals in Minneapolis and Houston who were treated with ciprofloxacin or trimethoprim/sulfamethoxazole. No significant differences in recurrence of symptoms or adverse events occurred. The findings support the use of a 7-day course of ciprofloxacin or trimethoprim/sulfamethoxazole as an alternative to a 14-day course for treatment of afebrile men with UTI, the study authors wrote.
Countries shortcomings in tackling antibiotic resistance spotlighted umn.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from umn.edu Daily Mail and Mail on Sunday newspapers.
LamiadLamai / iStock
The pandemic isn t over yet, but with more and more Americans getting vaccinated against COVID-19 and the light at the end of the pandemic tunnel becoming a little brighter every day at least in the United States many clinicians, scientists, and public health advocates are calling for renewed attention to an infectious disease threat that was in the spotlight before the pandemic arrived.
Prior to the pandemic, antimicrobial resistance (AMR) was considered one of the major looming health threats facing the world, if not
the looming threat. But over the past year, COVID-19, and its multifaceted impact on society, has pushed AMR further back on the agenda, both for the public and policy makers.
The pandemic isn’t over yet, but with more and more Americans getting vaccinated against COVID-19 and the light at the end of the pandemic tunnel becoming a little brighter every day at least in the United States many clinicians, scientists, and public health advocates are calling for renewed attention to an infectious disease threat that was in the spotlight before the pandemic arrived.
The pandemic isn’t over yet, but with more and more Americans getting vaccinated against COVID-19 and the light at the end of the pandemic tunnel becoming a little brighter every day at least in the United States many clinicians, scientists, and public health advocates are calling for renewed attention to an infectious disease threat that was in the spotlight before the pandemic arrived.